Works matching DE "INTRA-Cellular Therapies Inc."

Deal watch: Intra-Cellular Therapies and Takeda to develop PDE1 inhibitors for schizophrenia.

Published in:

Nature Reviews Drug Discovery, 2011, v. 10, n. 5, p. 329, doi. 10.1038/nrd3438

Publication type:

Article